Premorbid Social Functioning and Affective Symptoms Predict Subjective Outcome Among Outpatients With Schizophrenia

Frontiers in Psychiatry
Christine M HoertnaglAlex Hofer

Abstract

Improving the subjective outcome of patients is an important target in the treatment of schizophrenia. Accordingly, the aim of the present study was to examine the association of factors deemed relevant in this context, i.e., premorbid functioning, residual symptoms, and side effects of antipsychotic medication, with subjective outcome. To this end, 70 clinically stable outpatients with schizophrenia were included into a cross-sectional study. Premorbid functioning, psychopathology, and side effects were assessed by using the Premorbid Adjustment Scale, the Positive and Negative Syndrome Scale, and the Udvalg for Kliniske Undersogelser Side Effect Rating Scale, respectively. Subjective outcome was measured in terms of life satisfaction (Life Satisfaction Questionnaire), self-esteem (Index of Self-Esteem), and needs for care (Berliner Bedürfnisinventar). Both premorbid social functioning and affective symptoms predicted life satisfaction, self-esteem, and patients' basic needs, whereas positive and negative symptoms predicted needs in the health, social, and functional domains. Concerning side effects, parkinsonism and akathisia showed a significant negative correlation with self-esteem. These findings highlight the complex natu...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Feb 1, 1995·Schizophrenia Research·J P LindenmayerR B Hyman
Nov 1, 1994·The Journal of Nervous and Mental Disease·J P LindenmayerS Grochowski
Feb 1, 1997·Social Psychiatry and Psychiatric Epidemiology·J P OliverW Kaiser
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S BrowneE O'Callaghan
Dec 1, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·B G LinkJ C Phelan
Feb 13, 2002·The Journal of Clinical Psychiatry·Alex HoferW Wolfgang Fleischhacker
Apr 12, 2002·Acta Psychiatrica Scandinavica·L GaiteUNKNOWN EPSILON Study Group
Oct 14, 2003·Schizophrenia Bulletin·S OchoaUNKNOWN NEDES Group
Jun 17, 2004·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·A George Awad, Lakshmi N P Voruganti
Oct 8, 2004·Schizophrenia Research·Graham ThornicroftUNKNOWN EPSILON Study Group
Jun 29, 2005·Schizophrenia Research·Stefan LeuchtRolf R Engel
Aug 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Mirella RuggeriMichele Tansella
Aug 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·W Wolfgang FleischhackerAngelika Mehnert
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HoferW Wolfgang Fleischhacker
Nov 29, 2005·European Archives of Psychiatry and Clinical Neuroscience·Alex HoferW Wolfgang Fleischhacker
Jan 6, 2007·Schizophrenia Bulletin·Shaun M Eack, Christina E Newhill
Jul 14, 2007·Schizophrenia Research·N BrillM Weiser
Oct 9, 2007·Schizophrenia Research·Jenille M NarvaezThomas L Patterson
Oct 19, 2007·Acta Psychiatrica Scandinavica·T Burns, D Patrick
Oct 30, 2008·Schizophrenia Research·Robert BodénLeif Lindström
Jan 24, 2009·Psychiatry Research·Ricardo Saracco-AlvarezAna Fresán
Jul 1, 1992·Psychological Bulletin·J Cohen
Jun 1, 2010·Journal of the International Neuropsychological Society : JINS·Carmen SimonsenOle A Andreassen
Dec 15, 2010·International Journal of Mental Health Systems·Anna GaluppiLuigi Grassi
Jan 31, 2012·Current Pharmaceutical Biotechnology·E KaramatskosD Naber
Nov 5, 2013·Schizophrenia Research·Gagan FervahaGary Remington
Apr 30, 2014·Schizophrenia Bulletin·W Wolfgang FleischhackerPeter Woodruff
Jun 14, 2017·Psychiatry Research·Alex HoferW Wolfgang Fleischhacker
Aug 8, 2017·CNS & Neurological Disorders Drug Targets·Maurizio PompiliAndrea Fiorillo
Oct 11, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·A HoferH Uchida
Jul 10, 2018·Acta Psychiatrica Scandinavica·P BucciUNKNOWN Italian Network for Research on Psychoses

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
ISE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.